Panagora Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,932
| Closed | -$89K | – | 2911 |
|
|
2020
Q2 | $89K | Sell |
4,932
-13,888
| -74% | -$251K | ﹤0.01% | 1824 |
|
|
2020
Q1 | $134K | Sell |
18,820
-57,208
| -75% | -$407K | ﹤0.01% | 1589 |
|
|
2019
Q4 | $1.82M | Buy |
+76,028
| New | +$1.82M | 0.01% | 822 |
|
|
2018
Q4 | – | Sell |
-6,336
| Closed | -$169K | – | 2580 |
|
|
2018
Q3 | $169K | Hold |
6,336
| – | – | ﹤0.01% | 1731 |
|
|
2018
Q2 | $239K | Sell |
6,336
-46,986
| -88% | -$1.77M | ﹤0.01% | 1601 |
|
|
2018
Q1 | $1.74M | Sell |
53,322
-3,803
| -7% | -$124K | 0.01% | 925 |
|
|
2017
Q4 | $2.78M | Buy |
57,125
+48,588
| +569% | +$2.37M | 0.01% | 743 |
|
|
2017
Q3 | $461K | Buy |
+8,537
| New | +$461K | ﹤0.01% | 1378 |
|
|
2017
Q1 | – | Sell |
-11,594
| Closed | -$260K | – | 2485 |
|
|
2016
Q4 | $260K | Sell |
11,594
-12,433
| -52% | -$279K | ﹤0.01% | 1663 |
|
|
2016
Q3 | $546K | Sell |
24,027
-25,430
| -51% | -$578K | ﹤0.01% | 1417 |
|
|
2016
Q2 | $1.17M | Buy |
49,457
+35,150
| +246% | +$829K | 0.01% | 1061 |
|
|
2016
Q1 | $292K | Buy |
14,307
+14,113
| +7,275% | +$288K | ﹤0.01% | 1519 |
|
|
2015
Q4 | $10K | Sell |
194
-67
| -26% | -$3.45K | ﹤0.01% | 2218 |
|
|
2015
Q3 | $11K | Sell |
261
-201
| -44% | -$8.47K | ﹤0.01% | 2215 |
|
|
2015
Q2 | $21K | Buy |
+462
| New | +$21K | ﹤0.01% | 2302 |
|
|
2014
Q3 | – | Sell |
-265
| Closed | -$8K | – | 2394 |
|
|
2014
Q2 | $8K | Hold |
265
| – | – | ﹤0.01% | 2293 |
|
|
2014
Q1 | $7K | Buy |
+265
| New | +$7K | ﹤0.01% | 2288 |
|